BIG
JAZZ icon

Brooklyn Investment Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Brooklyn Investment Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$816K Buy
4,318
+1,275
+42% +$223K 0.03% 676
2025
Q4 		$519K Buy
+3,043
New +$467K 0.02% 636
2025
Q3 		– Sell
-797
Closed -$84.6K – 1694
2025
Q2 		$84.6K Buy
797
+245
+44% +$26.6K 0.01% 1033
2025
Q1 		$68.5K Buy
552
+444
+411% +$57.9K 0.01% 646
2024
Q4 		$13.3K Sell
108
-1
-0.9% -$118 ﹤0.01% 884
2024
Q3 		$12.1K Buy
+109
New +$11.9K ﹤0.01% 745

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Brooklyn Investment Group's JAZZ Position: Q1 2026 in Review

Brooklyn Investment Group increased its Jazz Pharmaceuticals (JAZZ) stake by 42% in Q1 2026, buying an estimated $223K and bringing the position to 4,318 shares worth $816K. The position accounts for 0.03% of the portfolio, ranked #676.

Brooklyn Investment Group first reported a position in JAZZ in Q3 2024 and has held it in 6 quarters since. 573 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Brooklyn Investment Group held 4,318 shares of Jazz Pharmaceuticals worth $816K as of Q1 2026.
  • Brooklyn Investment Group bought 1,275 Jazz Pharmaceuticals shares in Q1 2026, an estimated $223K.
  • Jazz Pharmaceuticals made up 0.03% of Brooklyn Investment Group's portfolio in Q1 2026, its #676 holding.
  • Brooklyn Investment Group first reported a position in Jazz Pharmaceuticals in Q3 2024 and has held it in 6 quarters since.
  • 573 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.